Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Liver Cancer treatment details. Chemotherapy. Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Survival: 6.9 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: United States
City/State/Province: Boston, Massachusetts
Hospital: Dana-Farber Cancer Institute
Journal: Link
Date: 6/2002

Patients: This Phase II study involved 30 patients with measurable, unresectable, or metastatic hepatocellular (liver) carcinoma.

Treatment: Treatment consisted of the chemotherapy drug gemcitabine.

Toxicity: Fourteen patients experienced grade 3-4 neutropenia. One patient experienced Grade 3 thrombocytopenia. Other toxicities included nausea/vomiting (grade 2-3) and fatigue (grade 2).

Results: The median survival period was 6.9 months.

Support: The study was supported by Eli Lilly, Inc. Eli Lilly markets gemcitabine.

Correspondence: Charles S. Fuchs, MD

E-mail to a Friend Email Physician More Information